SER Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Serina Therapeutics Inc (SER) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is experiencing significant financial declines, lacks positive trading trends, has no recent news or catalysts, and technical indicators suggest a bearish trend. Additionally, there are no proprietary trading signals or influential trades to support a buy decision.
The MACD is slightly positive but contracting, RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.458 and resistance at 1.68. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congressional trading data.
is down -1.06%, indicating a weak market environment.
In Q3 2025, Serina Therapeutics reported a complete revenue drop to 0, a net income loss of -$4,585,000 (-425.18% YoY), and an EPS decline to -0.44 (-438.46% YoY). Despite a gross margin of 100%, the financials show no signs of growth or recovery.
No analyst rating or price target data available.
